Spinal Surgery: Laminectomy and Fusion
Customize your policy alerts
Sign up for Aetna Policy 0743 alerts
Get alerted when Policy 0743 changes without checking for updates manually.
Monitor payer policy activity
Medical necessity criteria and coverage guidance for cervical, thoracic, lumbar, sacral laminectomy and spinal fusion procedures for Aetna members, including indications, prerequisites, and select procedural notes affecting authorization and reimbursement.
No material clinical or coverage changes in this revision.
Coverage and Medical Necessity Criteria
inv-01: COVERAGE CRITERIA
Covered when ALL of the following are met
ALL of the following
- Rule-out other causes: All other reasonable sources of pain and/or neurological deficit have been ruled out, including significant pathology at other spinal level(s) on advanced imaging that are not part of the surgical request.
- Clinical signs: Member has signs or symptoms of neural compression (radiculopathy, neurogenic claudication, or myelopathy) associated with the levels being treated.
- Imaging: CT or MRI demonstrates central, lateral recess, or foraminal stenosis graded moderate to severe (not mild/mild‑to‑moderate), or nerve root/spinal cord compression at levels corresponding to clinical findings.
- Conservative therapy: Member has failed at least 6 weeks of conservative therapy (see waiver exceptions).
- ADL limitation: Member's activities of daily living are limited by symptoms of neural compression.
ALL of the following
- Applicability: Applies to cervical laminectomy and/or cervical discectomy with or without fusion for herniated disc or other causes of cord/nerve root compression.
inv-02: COVERAGE CRITERIA
Covered when ALL of the following are met
ALL of the following
- Rule-out other causes: All other reasonable sources of pain and/or neurological deficit have been ruled out, including significant pathology at other spinal level(s) on advanced imaging that are not part of the surgical request.
- Clinical signs: Member has signs or symptoms of neural compression (radiculopathy, neurogenic claudication, myelopathy) associated with the levels being treated.
- Imaging: CT or MRI demonstrates central, lateral recess, or foraminal stenosis graded moderate to severe, or nerve root/spinal cord compression at the levels corresponding with clinical findings.
- Conservative therapy: Member has failed at least 6 weeks of conservative therapy (unless a waiver applies).
- ADL limitation: Member's activities of daily living are limited by symptoms of neural compression.
ALL of the following
- Applicability: Applies to thoracic laminectomy and to lumbar laminectomy for herniated disc when above criteria are met.
inv-03: COVERAGE CRITERIA
Covered when ALL of the following are met
ALL of the following
- Rule-out other causes: All other reasonable sources of pain and/or neurological deficit have been ruled out.
- Clinical signs: Member has signs or symptoms of neural compression (radiculopathy, neurogenic claudication, or myelopathy) at the levels being treated.
- Imaging: CT or MRI indicates central, lateral recess or foraminal stenosis (moderate to severe) or nerve root/spinal cord compression at corresponding levels.
- Conservative therapy: Failed at least 6 weeks of conservative therapy unless a waiver applies.
- ADL limitation: Activities of daily living are limited by symptoms of neural compression.
ANY of the following
- Rapid progression exception: If rapid neurologic deterioration (eg, foot drop, saddle anesthesia, bladder or bowel dysfunction) is present, decompression may be indicated without the full conservative trial.
inv-04: COVERAGE CRITERIA — ANY-of indications
Covered when ANY of the following are present
ANY of the following
- Fracture with displaced fragment: Spinal fracture with displaced fragment(s) causing moderate or worse stenosis or nerve compression on imaging with corresponding signs/symptoms.
- Infection: Spinal infection confirmed by imaging (and/or biopsy).
- Tumor: Spinal tumor (primary or metastatic) confirmed by imaging studies.
- Epidural hematoma confirmed by imaging studies.
- Cysts causing compression: Synovial, Tarlov (perineurial/sacral meningeal), or arachnoid cysts causing cord or nerve root compression with unremitting pain and corresponding neurologic deficit after failure of 6 weeks of conservative therapy (unless waived).
ANY of the following
- Urgent indications: These indications may waive conservative-management requirements and justify earlier decompression (eg, cord compression, cauda equina syndrome, myelopathy, severe weakness, progressive neurologic deficit).
inv-05: COVERAGE CRITERIA — Covered in treatment of listed conditions
Covered in treatment of any of the following
ANY of the following
- Tumor involving vertebrae: Tumors involving one or more vertebrae as documented on imaging and pathology workup.
- >50% compression fracture: >50% vertebral body compression fracture.
- Retropulsed fragments: Retro-pulsed bone fragments causing canal compromise.
- Vertebral body pathology causing stenosis: Symptomatic moderate or greater central canal stenosis caused by vertebral body pathology (fracture, tumor, congenital or acquired deformity).
ALL of the following
- Corpectomy scope: Vertebral corpectomy denotes removal of half or more of the vertebral body (not minor osteophyte removal) when one of the above conditions is present.
inv-06: COVERAGE CRITERIA — Covered when any of the following indications are met
Covered when any of the following indications are met
ANY of the following
- Cervical kyphosis with cord compression: Cervical kyphosis associated with spinal cord compression.
- Pseudoarthrosis: Symptomatic pseudarthrosis with radiographic demonstration of non-union after 12 months since fusion or with hardware failure (note nicotine‑cessation documentation requirements for non-urgent cases).
- Unstable fractures: Burst fractures, fracture‑dislocation or locked facets with mechanical instability confirmed by imaging; fusion may be combined with laminectomy.
- Infection or tumor: Spinal infection or tumor confirmed by imaging, where fusion may be required as part of treatment.
ALL of the following
- Pseudoarthrosis nicotine note: For pseudoarthrosis not associated with hardware failure, nicotine‑free status for at least 6 weeks is required for non‑urgent cases; lab confirmation (nicotine/cotinine ≤10 ng/ml) is required for recent users.
inv-07: COVERAGE CRITERIA
Covered when any of the following are met
ANY of the following
- Scoliosis criteria: Scoliosis with Cobb angle >40° in skeletally immature or >50° in skeletally mature adults with functional impairment after 3 months of conservative management.
- Thoracic kyphosis causing cord compression or kyphotic curve >75° refractory to bracing after 3 months conservative management.
- Thoracic pseudarthrosis after 12 months since fusion or with hardware failure; nicotine‑cessation requirements apply for non‑urgent cases.
- Unstable fractures/infection/tumor: Burst fractures, spinal infection, or tumor confirmed by imaging where fusion is indicated.
ALL of the following
- Documentation: Imaging confirmation and documentation of failed conservative management as specified are required.
inv-08: COVERAGE CRITERIA
Covered when any of the following are met
ANY of the following
- Adult scoliosis with Cobb angle >50° and functional impairment after 3 months conservative management.
- Lumbar pseudarthrosis after 12 months since fusion or with hardware failure (nicotine‑cessation requirements for non‑urgent cases).
- Flatback with sagittal imbalance: Iatrogenic or degenerative flatback with significant sagittal imbalance that has failed 3 months of conservative management when fusion with osteotomy/interbody implants is planned.
- Spondylolisthesis with instability: Significant spondylolisthesis (grades II–V) with symptomatic unremitting pain failing 6 weeks of conservative therapy, or dynamic instability (≥4 mm translation or ≥10° angular motion) failing 6 weeks of conservative therapy.
ALL of the following
- Sagittal imbalance thresholds: Significant sagittal imbalance defined per standing radiographs (eg, SVA, pelvic tilt, PI–LL mismatch as applicable) when fusion with deformity correction is contemplated.
inv-09: COVERAGE CRITERIA — Lumbar/thoracic decompression indications and instability criteria
Covered when lumbar/thoracic decompression is indicated and any of the following create or reflect instability
ANY of the following
- Flexion-extension instability: Segmental instability demonstrated by gross movement on flexion‑extension radiographs.
- Anterolisthesis: Decompression coincides with any degree of anterolisthesis (grades I–V).
- Intraoperative iatrogenic instability: Documented intraoperative iatrogenic instability during initial primary laminectomy/discectomy that necessitates fusion.
- Revision creating instability: Revision decompression expected to create iatrogenic instability (eg, facet joint excision >50% bilaterally or complete excision of one facet).
ALL of the following
- Decision basis: Fusion with decompression is indicated when decompression is necessary and any of the above instability criteria are met.
inv-10: COVERAGE CRITERIA
Covered when ALL of the following are met
ALL of the following
- Laminoplasty criteria: At least moderate cervical central stenosis at ≥2 levels where ≥2 vertebral segments will be decompressed.
- Rule-out other causes: All other reasonable sources of pain or neurologic deficit have been ruled out.
- Clinical myelopathy: Signs or symptoms of spinal cord compression (myelopathy) associated with the levels treated.
- Imaging: CT or MRI indicates central stenosis graded moderate to severe or spinal cord compression at corresponding levels.
- No motion/kyphosis: Cervical flexion/extension x‑rays show ≤3 mm motion and no cervical kyphosis.
- Conservative therapy: Failed at least 6 weeks of conservative therapy unless a waiver applies.
ALL of the following
- Applicability: Laminoplasty is appropriate only when alignment and motion criteria are met; axial neck pain and kyphosis are relative contraindications.
inv-11: COVERAGE CRITERIA
Removal considered medically necessary when ANY of the following criteria are met
ANY of the following
- Neurologic complication related to instrumentation (eg, screw compressing a nerve root causing radiculopathy).
- Post‑traumatic mass or pain: New pain or protruding mass at operative site after significant spinal trauma.
- Severe pain after healed fusion: Severe back or neck pain after fusion has healed related to instrumentation that has failed conservative management including ≥6 weeks of formal in‑person physical therapy in the past year.
- Infection: Spinal infection involving instrumentation.
- Hardware migration/failure: Symptomatic rod, hook, or screw migration, dislodgement, or breakage.
- Vascular complications attributable to instrumentation.
- Required for further surgery: Further approved surgery requires removal of the instrumentation.
ALL of the following
- Reimbursement note: Removal integral to an approved fusion with insertion of new instrumentation at the same levels is not separately reimbursable.
inv-12: Removal of posterior instrumentation - medically necessary
Removal of posterior spinal instrumentation is considered medically necessary when ANY of the following are met:
ANY of the following
- Posterior: neurologic complication: Neurologic complication related to ongoing posterior instrumentation (eg, screw compressing nerve root).
- Posterior: post‑traumatic mass/pain: New pain or protruding mass at operative site after significant spinal trauma.
- Posterior: severe pain after fusion: Severe back or neck pain after fusion has healed related to instrumentation that has failed conservative management including ≥6 weeks formal in‑person physical therapy in the past year.
- Posterior: infection: Spinal infection involving posterior instrumentation.
- Posterior: hardware migration/failure: Symptomatic rod, hook, or screw migration, dislodgment, or breakage.
- Posterior: vascular complications: Vascular complications from instrumentation.
- Posterior: required for further surgery: Further approved surgery that requires removal of instrumentation.
ALL of the following
- Operational note: Conservative management requirement defined in policy footnote; removal integral to approved fusion with new instrumentation at same levels is not separately reimbursable.
inv-13: Removal of anterior instrumentation - medically necessary
Removal of anterior spinal instrumentation is considered medically necessary when ANY of the following are met:
ANY of the following
- Anterior: required for further surgery: Further approved surgery requires removal of the anterior instrumentation.
- Anterior: neurologic/vascular complication: Neurologic or vascular complication related to the ongoing presence of anterior instrumentation.
- Anterior: instrumentation failure/migration: Instrumentation failure or migration that could cause neurologic or vascular complications.
- Anterior: infection: Spinal infection involving anterior instrumentation.
- Anterior: dysphagia: Dysphagia related to esophageal compression by anterior cervical implants confirmed by ENT evaluation or barium swallow.
ALL of the following
- Reimbursement note: Removal necessary for approved fusion that inserts new instrumentation at same levels is not separately reimbursable.
inv-14: Computer-assisted surgical navigation — approvable when ALL documented
Computer-assisted surgical navigation is approvable when ALL of the following are documented:
ALL of the following
- System identification: Identification of the stereotaxic/navigation system used.
- Registration and imaging review: Registration and review of imaging data sets with verification of accuracy documented.
- Intraoperative use of the navigation system is documented.
- Implant placement: Fusion implants are being placed during surgery (navigation is approvable when used for instrumentation placement).
ALL of the following
- Limitations: Navigation is not approvable for routine decompression procedures (exceptions may apply for tumor decompressions).
inv-15: Conservative management and waivers
Conservative management requirement and waiver conditions:
ALL of the following
- Conservative measures: Recent (within past year) conservative measures required: patient education; active in‑person physical therapy for the entire required duration (6 weeks or 3 months depending on indication); medications (NSAIDs, acetaminophen, or tricyclic antidepressants); and, where appropriate, identification/management of anxiety or depression.
- Documentation: Physical therapy must be confirmed by PT notes or claims history.
ANY of the following
- Waivers of conservative therapy: Waiver permitted for: (1) spinal cord compression; (2) stenosis causing cauda equina syndrome; (3) stenosis causing myelopathy (cervical or thoracic); (4) stenosis causing severe weakness at requested level(s) (MRC ≤4‑minus); (5) progressive neurologic deficit on serial exams; (6) severe stenosis with instability when fusion requested; (7) PT discharge note documenting inability to tolerate further PT due to exceptional pain.
inv-16: Preoperative optimization
Preoperative medical optimization — requirements for elective fusion and laminectomy:
ALL of the following
- Nicotine cessation: For spinal fusion, member should be nicotine‑free for at least 6 weeks prior to surgery; for recent users, lab verification (blood/urine nicotine or cotinine ≤10 ng/ml within 6 weeks) is required unless urgent indication applies.
- Diabetes control: For elective laminectomy and fusion, diabetic members should have HbA1c < 8% within 3 months prior to surgery unless an urgent indication applies.
- Preoperative exam: Medical records must document a preoperative physical examination including a neurologic exam performed by or reviewed by the operating surgeon.
ANY of the following
- Urgent indications exempt: Urgent indications that may obviate optimization include myelopathy, cauda equina syndrome, severe/progressive weakness, associated infection/tumor, or acute fracture.
inv-17: Not medically necessary / Experimental
Procedures considered experimental, investigational, or unproven (not covered):
ANY of the following
- Experimental/unproven list: Avulsion of spinal nerves; laminectomy and/or fusion for indications not listed as medically necessary; cervical laminoplasty for cervical kyphosis or mechanical axial neck pain without myelopathy; certain fusion devices/procedures (eg, ILIF, Coflex‑F); computer‑assisted navigation for laminectomies; paraspinal muscle flap closure/tissue transfer billed separately for wound closure; procedures for Bertolotti's syndrome without clear supportive evidence; other procedures identified as investigational in the policy.
ALL of the following
- Coding note: Robotic assistance is considered integral to the primary procedure and not separately reimbursable when policy specifies.
inv-18: General coverage linkage between procedures and diagnoses
Coverage for listed CPT procedures applies when the policy's selection criteria (clinical indications) are met for the associated ICD-10 diagnoses.
ALL of the following
- Linkage: Procedure CPT codes are covered when accompanied by an ICD‑10 diagnosis listed as 'covered if selection criteria are met' and when the specific clinical selection criteria (imaging confirmation and corresponding neurologic deficit where required) are satisfied.
- Documentation requirement: Claims and prior authorization should include imaging and clinical documentation demonstrating that selection criteria are met.
ALL of the following
- Code matching: Use the CPT/HCPCS and ICD‑10 codes exactly as listed in the policy and ensure the clinical record supports the indicated diagnosis and selection criteria.
inv-19: Covered when selection criteria are met
Coverage contingent on meeting selection criteria (selection criteria text not present in this segment).
ALL of the following
- Coverage condition: Specific CPT and ICD‑10 codes listed in policy are covered only if the corresponding clinical selection criteria elsewhere in the CPB are met.
- Prior authorization implication: Many of the listed CPT codes are subject to prior authorization consistent with the policy's clinical criteria.
ALL of the following
- Coding caveat: Certain ICD‑10 codes (eg, nicotine dependence; tobacco use) are listed as not covered when used as primary indications for spinal procedures and may trigger denial if used incorrectly.
inv-20: Indications for consideration of laminectomy/fusion
Coverage is contingent on clinical selection criteria and conservative management history as described in the background; surgery is an option when criteria below are met.
ANY of the following
- Red-flag conditions: Presence of red‑flag conditions (infection, malignancy, acute fracture, rapidly progressing neurologic deficit such as cauda equina, bowel/bladder dysfunction, or severe/progressive weakness) may justify earlier surgical evaluation/intervention.
- Persistent disabling radiculopathy: Persistent and disabling radiculopathy with objective evidence of specific nerve root dysfunction on CT/MRI after failure of conservative therapy for at least 4–6 weeks.
- Instability/deformity: Lumbar instability (eg, spondylolisthesis), degenerative scoliosis, discitis, neoplastic collapse, or chronic fractures where fusion may be indicated after appropriate conservative care.
ALL of the following
- Shared decision-making: Surgical candidacy should include shared decision‑making discussing risks, benefits, and alternatives including intensive rehabilitation where appropriate.
inv-21: Prerequisites for lumbar fusion
When fusion is contemplated for axial low back pain or degenerative disease:
ALL of the following
- Prerequisites for fusion: Documented failure of comprehensive conservative therapy (often 6–12 months) appropriate to the indication; clear clinical‑to‑imaging correlation; consideration of intensive interdisciplinary rehabilitation as an alternative; shared decision‑making regarding risks and benefits.
- Appropriate indications: Fusion should be considered primarily for instability, refractory axial pain with supportive objective findings, deformity, or other specific indications described in the policy (eg, high‑grade spondylolisthesis, pseudarthrosis, deformity correction).
ALL of the following
- Documentation: Prior conservative treatments, duration, response, imaging correlation, and rationale for fusion technique selection should be documented.
inv-22: Medical necessity and indication groups
Coverage considerations and typical indications (synthesized from guidance and trials):
ALL of the following
- Spondylolisthesis with stenosis: Image‑confirmed degenerative spondylolisthesis with spinal stenosis and neurologic signs (eg, radicular leg pain, neurogenic claudication) with persistent symptoms despite appropriate conservative management (eg, ≥12 weeks) — decompression with or without fusion may be considered.
- When fusion favored: High‑grade slip (>50%), iatrogenic or traumatic spondylolisthesis, documented dynamic instability, or pseudarthrosis favor fusion.
- When fusion not preferred: Chronic non‑specific low back pain without neurologic compromise should receive structured non‑surgical care (intensive rehabilitation/CBT) prior to fusion given uncertain additional benefit.
ANY of the following
- Evidence basis: SPORT and other trials support careful selection: surgical benefit for spondylolisthesis cohorts observed in as‑treated analyses but requires documented chronicity and imaging correlation.
inv-23: Indication-specific coverage considerations
Evidence-based considerations for when fusion or decompression may be appropriate
ALL of the following
- Documentation recommended: Document selection rationale, prior conservative care, imaging correlation, and alternatives considered per guidelines and systematic reviews.
inv-24: Revision surgery/FBSS
Revision surgery and failed back surgery syndrome (FBSS) guidance:
ALL of the following
- Outcomes and selection: Revision surgery outcomes depend on accurate diagnosis, appropriate selection, and targeting the underlying pathology; documentation should support the indication.
inv-25: ADR and hybrid procedures
Artificial disc replacement (ADR) and hybrid constructs — coverage considerations:
ALL of the following
- Coverage implication: ADR or hybrid procedures should be considered in the context of the policy's evidence‑based selection criteria and documented clinical indications; where ADR/fusion evidence is uncertain, careful selection and documentation are required.
inv-26: Evidence-based coverage considerations for lumbar fusion
Evidence-based coverage considerations for lumbar fusion — summary guidance:
ALL of the following
- Indication-specific decision making: Coverage decisions for lumbar fusion should reflect that benefits vary by indication; greatest benefit is typically for spondylolisthesis and selected deformity cases, whereas fusion for non‑radicular axial LBP has uncertain added benefit over intensive non‑surgical care.
- Require documented conservative care: For degenerative indications without instability, require documentation of adequate conservative therapy (duration and content) and consideration of intensive rehabilitation alternatives prior to fusion.
- Prior authorization recommended: Given variable evidence and resource use, prior authorization to confirm indication and documentation is advisable for lumbar fusion requests.
ANY of the following
- Risk/benefit discussion: Shared decision‑making must include discussion of modest average benefits, complication and re‑operation risks, and alternatives including intensive rehabilitation.
inv-27: Coverage considerations for anterior corpectomy (ACCF/ACF) vs laminoplasty
Choice between anterior corpectomy/ADF and laminoplasty should consider canal occupying ratio and alignment:
ANY of the following
- Anterior approach favored: For cervical OPLL with canal occupying ratio ≥60% (or ≥50% in some analyses) or kyphotic alignment, anterior corpectomy/discectomy and fusion (ACCF/ADF) may yield greater neurologic recovery but with higher operative time, blood loss, complication and re‑operation rates.
- Laminoplasty favored: When canal occupying ratio is <60% with adequate lordotic alignment, laminoplasty may provide comparable neurologic outcomes with lower complication and re‑operation rates, provided flexion/extension motion and sagittal balance criteria are met.
ANY of the following
- Alignment and SVA considerations: Cervical alignment (lordosis vs kyphosis) and baseline sagittal vertical axis (eg, SVA≥40 mm) influence choice; high baseline SVA or kyphosis may favor fusion over laminoplasty.
inv-28: Procedure selection criteria and comparative outcomes
Evidence-based procedure selection and comparative outcomes — key points:
ALL of the following
- Canal occupying ratio thresholds: Subgroup analyses support posterior laminoplasty for lower canal occupying ratios (<50–60%), while anterior procedures (ACCF/ADF) may provide superior neurologic recovery when occupying ratio is ≥50–60%, balanced against higher complication/re‑operation risk.
- LF vs LAMP outcomes: Meta‑analyses and prospective cohorts show similar functional outcomes (JOA, NDI) for laminectomy+fusion (LF) versus laminoplasty (LAMP) in many cohorts, but LF is associated with higher total complication and nerve palsy rates; selection should be individualized.
- Evidence implication: Procedure selection should integrate canal occupying ratio, cervical alignment, baseline SVA, and patient‑specific risk/benefit considerations.
ANY of the following
- Documentation: Prior authorization and operative planning should document canal occupying ratio, alignment measures, and rationale for anterior versus posterior approach.
inv-29: Use of plastic surgeon–assisted paraspinal muscle flap or multi-layered closure
Use of plastic surgeon–assisted paraspinal muscle flap or multi‑layered closure — context and evidence:
ALL of the following
- Contexts favoring plastic closure: Consider plastic surgeon–assisted paraspinal muscle flap or multi‑layered closure in complex or high‑risk posterior spinal wounds (eg, revision surgeries, prior radiation, extensive soft‑tissue defects, instrumentation exposure, metastatic tumor resections) where primary closure by spine surgeon alone carries elevated wound‑complication risk.
- Evidence level: Evidence derives from retrospective single‑center series and is mixed; some studies report reduced wound complications in selected high‑risk cohorts while others show no clear advantage and higher seroma rates.
- Operational tradeoffs: Potential trade‑offs include longer operative time, longer hospital stays, increased seroma or drain use; decision should be individualized and documented.
ANY of the following
- Coverage stance: Plastic closure is not routinely reimbursable as a separate procedure for typical 1–4 level revision posterior thoraco‑lumbar fusions; separate reimbursement may be considered in appropriately selected high‑risk cases where documentation supports medical necessity.
inv-30: Occipito-cervical fusion and management of AOD
Occipito‑cervical fusion — indications and imaging guidance for atlanto‑occipital dissociation (AOD):
ALL of the following
- Diagnosis considerations: Use CT and MRI to evaluate cranio‑cervical junction anatomy and ligamentous integrity; apply radiographic thresholds (eg, BDI >10 mm; BAI anterior >12 mm or posterior >4 mm; condyle‑to‑C1 interval >1.4 mm) to define AOD.
- Indication for OCF: Occipito‑cervical fusion is indicated when AOD is diagnosed or suspected with imaging and/or instability that supports surgical fixation; posterior OCF with instrumentation is usual surgical treatment for CT‑documented unstable AOD.
- Risk of missed diagnosis: Missed AOD diagnosis is strongly associated with higher mortality; timely diagnosis and documentation are essential.
ANY of the following
- Documentation: Prior authorization/operative planning should include CT/MRI findings, applied radiographic criteria, and rationale for OCF versus non‑operative management.
inv-31: Occipito‑cervical fusion decision framework in lower clival chordoma
Decision framework for occipito‑cervical fusion in lower clival chordoma based on occipital condyle (OC) integrity:
ALL of the following
- OCF recommended when: All of the following: intact OC < 60% on preoperative imaging (ie, <60% of the condyle intact) — OCF performed in the cited series for such cases.
- OCF may be avoided when: All of the following: intact OC ≥70% with intact apical ligament and tectorial membrane — these patients were treated without OCF in the study.
- Intermediate OC 60–69%: For intact OC 60–69%, perform OCF if ligaments are eroded; if ligaments intact, OCF may be avoided — ligament integrity determines final decision.
ALL of the following
- Documentation: Preoperative assessment should include percent OC intact, Hounsfield units, and evaluation of apical ligament and tectorial membrane to guide OCF decision.
inv-32: Conservative management before lumbar spine surgery
Use conservative treatments prior to considering surgery for lumbar spinal stenosis unless urgent indications exist
ALL of the following
- Evidence note: Randomized and prospective trials show variable benefits for surgery versus conservative care; document prior conservative care, response, and justification for surgery.
inv-33: Computer‑assisted/robotic navigation in pedicle screw placement
Evidence and operational considerations for computer‑assisted/robotic navigation in pedicle screw placement:
ANY of the following
- Coverage stance: Navigation/robotic assistance is approvable when used for instrumentation placement per policy documentation requirements; registration failures, additional pre‑op imaging time, and lack of long‑term PRO data are recognized limitations.
Exploration of spinal fusion (CPT 22830) is considered incidental when encountered during other spinal procedures in the same anatomic region and therefore cannot be separately authorized or reimbursed in combination with other spinal procedures in that area. If intraoperative exploration for pseudoarthrosis meets the specific criteria for reimbursement (e.g., documented pseudarthrosis indications), 22830 may be reimbursed when no additional procedures are performed; otherwise billing 22830 separately when incidental is considered not medically necessary.
The policy excludes certain conditions from routine fusion indications. Examples explicitly noted include pars defects/pars fractures, subacute or chronic compression fractures, and compression fractures without retropulsion causing significant canal stenosis. Also excluded are stable isolated fractures such as chronic stable odontoid fractures, spinous process fractures, transverse process fractures and stable isolated pedicle fractures unless other specific fusion criteria are met.
When removal of instrumentation is performed solely because it is required to insert new instrumentation at the same levels as an approved fusion, the removal is considered an integral part of the new fusion procedure and is not separately reimbursable. Removal for other medically necessary indications (infection, hardware failure, neurologic or vascular complication, or when further surgery requires removal) may be reimbursed per the policy.
Illustrative ICD-10 diagnosis examples that are identified in the policy as not covered for the CPB indications include codes for nicotine dependence (F17.200–F17.299), tobacco use (Z72.0), and other cervical/thoracic/lumbar injury or complication codes when used as primary indications without meeting selection criteria.
Specific ICD-10 examples explicitly listed as not covered for CPB indications include F17.200–F17.299 (nicotine dependence) and Z72.0 (tobacco use) when cited as the primary indication for spinal procedures in the CPB.
Examples of CPT/HCPCS codes the policy identifies as not covered for CPB-listed indications include 61783 (stereotactic computer-assisted/navigation procedure; spinal), S2900 (techniques requiring use of a robotic surgical system), 64772 (transection/avulsion of spinal nerve), and tissue-transfer/flap codes such as 14000–15734 when billed separately for routine paraspinal closure.
Routine instrumented fusion is not recommended as a standard treatment following an isolated primary disc excision for herniated lumbar disc causing radiculopathy. In general, fusion after primary disc excision should only be considered when objective indications such as documented instability or other coverage criteria are met rather than routinely performed following discectomy.
For non‑radicular low back pain associated with common degenerative changes, randomized trials and guideline summaries show that intensive interdisciplinary rehabilitation (including cognitive‑behavioral components) provides outcomes comparable to fusion. Therefore, fusion without documented failure of an intensive rehabilitation program is not clearly superior and is generally not supported as the default treatment for non‑radicular LBP.
Preoperative axial neck pain is identified as a relative contraindication to laminoplasty because disruption of posterior musculature during the procedure can worsen axial neck pain. Clinicians should weigh pre‑operative axial pain when selecting laminoplasty and consider alternative approaches when axial neck pain is prominent.
In patients with closed spinal dysraphism who have longstanding, severe, and static neurologic deficits, surgical intervention is unlikely to provide meaningful benefit. The policy cites evidence that severely disabled patients with static deficits related to closed spinal dysraphism are less likely to improve after surgery.
Laminoplasty is not recommended for patients who have cervical spondylotic myelopathy with kyphotic deformity, particularly when there is a large pre‑operative range of motion; these alignment and motion characteristics favor anterior or fusion approaches rather than laminoplasty.
Retrospective series comparing plastic surgeon–assisted paraspinal muscle flap closure with standard spine closure did not demonstrate a consistent advantage in routine revision cases; some studies reported increased seroma formation and longer hospital length of stay with plastic closures. Thus, routine separate reimbursement for paraspinal muscle flap closure is not supported for typical 1–4 level revision posterior thoraco‑lumbar fusions.
Acute low back pain is usually self‑limiting and resolves in less than 6 weeks for most patients. The policy emphasizes that conservative measures (activity modification, physical therapy, medications, and injections such as ESIs when appropriate) are recommended initially and that surgery is generally reserved for patients who fail adequate conservative care or who have urgent neurologic findings.
Surgery for Bertolotti’s syndrome (lumbo‑sacral transitional vertebrae) lacks high‑quality evidence demonstrating superiority over conservative management. The literature consists largely of small retrospective reports without randomized or prospective comparative trials; therefore, routine surgical treatment for Bertolotti’s syndrome is not established as effective.
Codes and Diagnostic/Procedure Lists
| 22830 | Exploration of spinal fusion |
| 61783 | Stereotactic computer-assisted (navigational) procedure; spinal |
| 22840 | Posterior non-segmental instrumentation |
| 22842 | Posterior segmental instrumentation; 3 to 6 vertebral segments |
| 22844 | Posterior segmental instrumentation; 13 or more vertebral segments |
| 22845 | Anterior instrumentation; 2 to 3 vertebral segments |
| 22846 | Anterior instrumentation; 4 to 7 vertebral segments |
| 22847 | Anterior instrumentation; 8 or more vertebral segments |
| 22853 | Insertion of interbody biomechanical device(s) with integral anterior instrumentation |
| 22854 | Insertion of intervertebral biomechanical device(s) with integral anterior instrumentation to vertebral corpectomy defect |
| 22859 | Insertion of intervertebral biomechanical device(s) without interbody arthrodesis |
| 63075 | Discectomy, anterior, with decompression; cervical, single interspace |
| 63076 | Cervical, each additional interspace |
| 63081 | Vertebral corpectomy, anterior approach; cervical, single segment |
| 63082 | Cervical, each additional segment |
| 63035 | Laminotomy (hemilaminectomy) with decompression; each additional interspace |
| 83036 | Hemoglobin; glycosylated (A1C) |
| 83037 | Glycosylated (A1C) by device cleared by FDA for home use |
| 99406 | Smoking and tobacco use cessation counseling visit; intermediate |
| 99407 | Smoking and tobacco use cessation counseling visit; intensive |
| 22222 | Osteotomy of spine, thoracic |
| 22532 | Arthrodesis, lateral extracavitary technique; thoracic |
| 22556 | Arthrodesis, anterior interbody technique; thoracic |
| 22800 | Arthrodesis, posterior, for spinal deformity, up to 6 segments |
| 63003 | Laminectomy with decompression; thoracic, 1-2 segments |
| 63016 | Laminectomy, thoracic, more than 2 segments |
| 63030 | Laminotomy (hemilaminectomy), lumbar, 1 interspace |
| 63042 | Laminotomy, lumbar, reexploration, single interspace |
| 63047 | Laminectomy, facetectomy and foraminotomy, single vertebral segment; lumbar |
| 63056 | Transpedicular approach with decompression; lumbar |
| 62330 | Percutaneous decompression with partial removal of ligamentum flavum; lumbar |
| C41.2 | Malignant neoplasm of vertebral column |
| D16.6 | Benign neoplasm of vertebral column |
| M50.00 | Cervical disc disorder with myelopathy |
| M54.12 | Radiculopathy, cervical region |
| G83.4 | Cauda equina syndrome |
| F17.200 - F17.299 | Nicotine dependence (ICD-10 codes listed as not covered if selection criteria are met) |
| Z72.0 | Tobacco use (ICD-10 code listed as not covered if selection criteria are met) |
| 22548 | Arthrodesis, anterior transoral or extraoral technique, clivus-C1-C2 (atlas-axis), with or without excision of odontoid process. |
| 22551 | Arthrodesis, anterior interbody, including disc space preparation, discectomy, osteophytectomy and decompression of spinal cord and/or nerve roots; cervical below C2. |
| 22552 | Each additional interspace (List separately in addition to code for separate procedure). |
| 22554 | Arthrodesis, anterior interbody technique; cervical below C2. |
| 22585 | Each additional interspace (List separately in addition to code for primary procedure). |
| 22590 | Arthrodesis, posterior technique, craniocervical (occiput-C2). |
| 22595 | Arthrodesis, posterior technique, atlas-axis (C1-C2). |
| 22600 | Arthrodesis, posterior or posterolateral technique, single level; cervical below C2 segment. |
| 22612 | Arthrodesis, posterior or posterolateral technique, single level; lumbar (with or without lateral transverse technique). |
| 22614 | Each additional vertebral segment (List separately in addition to code for primary procedure). |
| 72125 | Computed tomography, cervical spine; without contrast material. |
| 72141 | Magnetic resonance imaging, spinal canal and contents, cervical; without contrast material. |
| 75705 | Angiography, spinal, selective, radiological supervision and interpretation. |
| 78811 | Positron emission tomography (PET) imaging; limited area. |
| 78830 | Radiopharmaceutical localization of tumor... tomographic (SPECT) with concurrently acquired CT; single area. |
| 80323 | Alkaloids, not otherwise specified [Blood or Urinary Nicotine]. |
| 83036 | Hemoglobin; glycosylated (A1C). |
| 83037 | Glycosylated (A1C) by device cleared by FDA for home use. |
| 97110 - 97546 | Therapeutic procedures (physical therapy range). |
| 99406 | Smoking and tobacco use cessation counseling visit; intermediate. |
| 99407 | Smoking and tobacco use cessation counseling visit; intensive. |
| L0625 - L0651 | Lumbar-sacral orthosis [Lumbar bracing] (HCPCS range). |
| C41.2 | Malignant neoplasm of vertebral column. |
| C72.0 | Malignant neoplasm of spinal cord. |
| C79.31 - C79.52 | Secondary malignant neoplasm of brain and spinal cord; bone and bone marrow. |
| D16.6 | Benign neoplasm of vertebral column. |
| G06.1 | Intraspinal abscess and granuloma. |
| M48.01 - M48.05 | Spinal stenosis (cervical/thoracic). |
| M51.04 - M51.06 | Intervertebral disc disorders with myelopathy (thoracic/lumbar). |
| M54.11 - M54.13 | Radiculopathy (cervical). |
| G83.4 | Cauda equina syndrome. |
| M43.11 - M43.17 | Spondylolisthesis codes (various regions). |
| F17.200 - F17.299 | Nicotine dependence (listed as ICD-10 codes not covered for indications in the CPB). |
| Z72.0 | Tobacco use (listed as ICD-10 codes not covered for indications in the CPB). |
| 97110 - 97546 | Therapeutic procedures. |
| G89.11 | Acute pain due to trauma |
| G89.18 | Other acute postprocedural pain |
| M53.80 - M53.9 | Other specified dorsopathies |
| M54.10 - M54.18 | Radiculopathies |
| M54.2 | Cervicalgia |
| M54.30 - M54.32 | Sciatica |
| M54.40 - M54.42 | Lumbago with sciatica |
| M54.50 - M54.59 | Low back pain |
| M54.6 | Pain in thoracic spine |
| M54.9 | Dorsalgia, unspecified [backache] |
| 22855 | Removal of anterior instrumentation |
| 22212 | Osteotomy of spine, posterior or posterolateral approach, 1 vertebral segment; thoracic |
| 22216 | Each additional vertebral segment (list separately) |
| 22226 | Osteotomy of spine, including discectomy, anterior approach, single vertebral segment; each additional vertebral segment |
| 22612 | Arthrodesis, posterior or posterolateral technique, single interspace; lumbar |
| 22614 | Each additional interspace |
| 22630 | Arthrodesis, posterior interbody technique, including laminectomy/discectomy, single interspace, lumbar |
| 22632 | Each additional interspace |
| 22633 | Arthrodesis, combined posterior or posterolateral technique with posterior interbody technique, single interspace, lumbar |
| 22634 | Each additional interspace |
| 61783 | Stereotactic computer-assisted (navigational) procedure; spinal (not covered for indications listed) |
| S2900 | Surgical techniques requiring use of robotic surgical system (not covered for indications listed) |
| 64772 | Transection or avulsion of other spinal nerve, extradural (not covered for indications listed) |
| 14000 | Adjacent tissue transfer or rearrangement, trunk; defect 10 sq cm or less (paraspinal muscle flap closure not covered) |
| 14001 | Adjacent tissue transfer, defect 10.1–30.0 sq cm (not covered) |
| 14301 | Adjacent tissue transfer, any area; defect 30.1–60.0 sq cm (not covered) |
| 14302 | Each additional 30.0 sq cm (not covered) |
| 15734 | Muscle, myocutaneous, or fasciocutaneous flap; trunk (not covered) |
| 8E0W4CZ | ICD‑10‑PCS code used in dataset to identify robotic-assisted spinal fusion (as cited) |
| 8E0W0CZ | ICD‑10‑PCS code used in dataset to identify robotic-assisted spinal fusion (as cited) |
| 8E0W3CZ | ICD‑10‑PCS code used in dataset to identify robotic-assisted spinal fusion (as cited) |
| Mazor X Stealth Edition | named robotic system used in RCT protocol (device name referenced rather than a numerical code) |
| TINAVI | TINAVI orthopedic surgery robot referenced in comparative study |
Authorization, Documentation, and Billing Actions
Authorization for elective decompression/fusion — prior authorization implied
Prior authorization is implied for elective laminectomy or fusion procedures when the medical necessity criteria are met; requests should document imaging-confirmed moderate-to-severe stenosis or neural compression, failure of required conservative therapy, and correlated clinical findings to support authorization.
- Document CT or MRI demonstrating central/lateral recess or foraminal stenosis graded moderate–severe at levels corresponding to symptoms; imaging within past year preferred.
- Confirm failure of at least 6 weeks of conservative therapy unless a listed waiver applies (see policy).
- Provide clinical signs (radiculopathy, neurogenic claudication, myelopathy) and ADL impact.
Prior authorization for computer-assisted navigation (CPT 61783)
Authorization for stereotactic computer-assisted surgical navigation (CPT 61783) is approvable only when fusion implants are being placed and documentation shows system identification, registration and imaging review with verification of accuracy, and intraoperative use of the navigation system.
- Include the navigation system make/model and registration details in the request.
- Provide evidence that fusion implants will be placed during the procedure; navigation for routine decompression alone is not approvable.
Prior authorization applies to listed spine procedure CPT codes
Many spine procedure CPT codes listed in the policy (laminectomy, laminotomy, corpectomy, fusion, instrumentation) are subject to the policy's selection criteria and should be considered for prior authorization when applicable.
- Match the requested CPT codes to the policy's covered-if-selection-criteria-are-met lists when submitting authorization.
- Ensure clinical documentation demonstrates the selection criteria for the specific CPT code requested.
Prior authorization / selection-criteria required CPT codes
Certain fusion and related CPT codes are designated 'covered if selection criteria are met'—authorization must confirm that the patient meets those clinical selection criteria before coverage is approved.
- Include the relevant ICD-10 diagnosis that corresponds to policy selection criteria.
- Attach imaging and prior conservative therapy documentation mapped to the requested CPT codes.
Prior authorization required for major fusion/laminectomy codes
Major fusion, laminectomy and instrumentation CPT/HCPCS codes listed as covered when selection criteria are met require prior authorization consistent with the policy clinical criteria.
Prior authorization: conservative management and imaging
Prior authorization requests should verify documented attempts at conservative management and include imaging (MRI preferred) that confirms the pathology corresponding to symptoms.
- Provide dates and content of conservative care (PT notes, injections, medications) showing failure of therapy for required duration.
- Attach MRI/CT reports demonstrating the level(s) of neural compression.
Prior authorization to confirm appropriate indication
Because indications and outcomes vary substantially, prior authorization should confirm the appropriate clinical indication for fusion or decompression—ensuring chronicity, failed intensive non-surgical therapy when required, and consideration of alternatives.
- Document symptom duration, prior conservative or structured non-surgical therapies, and rationale for choosing fusion versus decompression-alone.
- Cite imaging-confirmed diagnosis that matches the requested surgical procedure.
Prior authorization recommended for lumbar fusion
Prior authorization is recommended for lumbar fusion procedures due to uncertain evidence and the need for careful patient selection—authorization should document indication (e.g., spondylolisthesis) and prior conservative care.
- Provide objective evidence of instability or diagnostic criteria (e.g., translation ≥4 mm, grades II–V spondylolisthesis) when fusion is requested.
- Include discussion of alternatives and shared decision-making.
Prior authorization not specified in this excerpt
No prior authorization statements are present in the cited background summary excerpts; when using those specific evidence-summary sections alone, administrative prior authorization rules are not specified.
- Background evidence sections describe trials and outcomes but do not define authorization procedures.
Prior authorization not specified in excerpt
The background evidence summaries provided do not state explicit prior authorization requirements for the studies discussed; authorization rules appear elsewhere in the policy.
- Use clinical policy sections (coverage criteria, CPT/ICD lists) rather than evidence-summary text to determine authorization needs.
Canal occupying ratio documentation recommended for procedure selection
When choosing anterior versus posterior approaches for OPLL or severe canal-occupying pathology, include the canal occupying ratio in the authorization documentation—subgroup thresholds (≈50–60%) inform procedure selection.
- Report measured canal occupying ratio on pre-op imaging; specify whether it is <50–60% or ≥50–60% to justify anterior decompression (ACCF/ADF) versus laminoplasty.
- Provide alignment/SVA data if relevant to approach selection.
Preoperative smoking cessation recommended (minimum 4 weeks)
The ERAS Society recommends combined smoking-cessation therapy for at least 4 weeks before lumbar fusion; document smoking-cessation counseling and plan in preoperative authorization materials.
- Include evidence of enrollment in smoking-cessation program and planned cessation timeline.
- For recent nicotine users, provide lab verification per policy (see nicotine cessation documentation requirements).
Prior authorization not specified in this section
This document segment discussing plastic-surgeon closure and wound-closure series does not provide explicit prior authorization instructions for use of plastic surgery; authorization should rely on the policy's administrative guidance rather than these study descriptions.
- Clinical series describe selective use in high-risk cases but do not mandate administrative prior authorization rules.
Document imaging and technique in authorization requests for OCF
When occipito‑cervical fusion is planned, include detailed imaging documentation (percent intact occipital condyle, ligament integrity, Hounsfield units) and specify the surgical approach and technique in the authorization request.
- Attach CT/MRI reports detailing OC intact percentage and ligamentous integrity.
- Describe planned instrumentation and whether navigation/robotic assistance or specific devices will be used.
Prior authorization for fusion with robotic/navigation-assisted instrumentation
For robotic- or navigation-assisted fusion procedures, obtain prior authorization using the standard fusion/instrumentation coding and include the planned device/system (make/model), the proposed levels, and justification for using robotic/navigation assistance.
- State the robotic/navigation system (e.g., Mazor X Stealth, TINAVI) and list levels and number of pedicle screws planned.
- Provide clinical rationale for navigation/robotic assistance (e.g., complex anatomy, deformity) and link to fusion indication.
Conservative therapy prerequisites (minimum 6 weeks; some indications longer)
Members must generally fail at least 6 weeks of conservative therapy before surgical authorization; some indications and fusion prerequisites may require longer (often 3 months or 6–12 months) depending on the condition.
- Supply PT records, medication trials, injection history, and other conservative care documentation covering the required duration.
- If a waiver is claimed, document the specific waiver indication (e.g., myelopathy, cauda equina, progressive neurologic deficit).
Conservative care required before fusion (often 6–12 months)
Policy background (e.g., AHRQ summaries) indicates conservative treatments are usually tried for at least 6 to 12 months before lumbar fusion is considered; authorization for fusion should include documentation of adequate conservative care for the timeframe applicable to the indication.
- For axial low back pain considered for fusion, provide documentation of comprehensive conservative care (often 6–12 months) or rationale for waiver.
- Include records of structured rehabilitation or intensive programs when available.
Step therapy preference for structured non-surgical treatment
Randomized trials support structured non-surgical therapy (intensive exercise/rehabilitation plus cognitive-behavioral therapy or supervised PT) as an alternative to fusion for many chronic low back pain cohorts; authorization for fusion should document trial of these structured therapies when indicated.
- Provide details of structured programs (duration, intensity, PT notes) and outcomes.
- If structured therapy was not feasible, document reasons (e.g., inability to tolerate due to pain).
Conservative therapy prerequisite for non-radicular LBP (intensive rehab/CBT)
For non-radicular low back pain with degenerative changes, authorization should include documentation that intensive rehabilitation with cognitive-behavioral emphasis was attempted, since such programs yield outcomes comparable to fusion.
- Attach program descriptions and patient participation/completion records when available.
- If fusion is requested without such therapy, provide justification based on clinical findings.
Conservative therapy before fusion — document adequate non-surgical care
Consider requiring documentation of adequate non-surgical management prior to lumbar fusion in degenerative low back pain absent specific indications; provide evidence that conservative management failed when submitting an authorization request.
- Document duration and types of non-surgical care and the patient's response.
- If fusion is for spondylolisthesis, ensure imaging-confirmed instability and symptom chronicity are documented.
No step therapy specified in background excerpts
No step therapy requirements are described in certain background excerpts; clinical judgment and policy selection criteria should guide authorization rather than those narrative sections alone.
- Refer to the formal coverage criteria and prior authorization modules for administrative requirements.
No step therapy mandate — MID may be alternative in selected cases
Comparative evidence suggests minimally invasive decompression (MID) may be an alternative to laminectomy with fusion for selected degenerative spondylolisthesis patients; authorization should document why MID is not appropriate when fusion is requested.
- Provide rationale for selecting fusion rather than MID (instability, higher-grade slip, deformity, failed prior decompression).
Canal occupying ratio high (≥50–60%) — document to justify anterior approach
When pre-operative canal occupying ratio is high (≥50–60%) in OPLL, anterior decompression (ACCF/ADF) may provide better neurologic recovery but with higher surgical trauma and re-operation risk; document occupying ratio when requesting authorization for anterior approaches.
- Specify the canal occupying ratio measured on imaging and explain how it influenced choice of ADF/ACCF.
- Include risk–benefit discussion in clinical rationale documentation.
No step therapy specified for immediate muscle flap closure — case-by-case use
Use of immediate muscle flap closure is described in clinical series for selected high-risk patients but is not presented as a mandated step therapy; authorization should be based on the CPB criteria rather than series-level descriptions.
- If plastic closure is requested, document specific high-risk features (prior radiation, prior infection, multiple revisions) and justify necessity.
Conservative care before lumbar surgery — document trials and responses
Authorization for lumbar surgery commonly requires documentation of an initial conservative approach (activity modification, PT, medications, injections when appropriate); include records showing such trials and outcomes.
- Provide PT notes, injection dates/results, medication trials, and ADL impact documentation.
- If urgent indications exist (progressive neurologic deficit, cauda equina), note waiver rationale.
Intra-operative verification expectations for robot-assisted screw placement
When robotic assistance is used for pedicle screw placement, authorization and operative documentation should include the surgeon's prior experience with the system and intra-operative verification steps (e.g., lateral fluoroscopy check of guide pin vs planned trajectory).
- Document intra-operative verification methods and surgeon/operator experience with the robotic/navigation system in the authorization request.
- Note plans for lateral fluoroscopy checks or other verification of guide needle/screw trajectory.
Pseudoarthrosis and nicotine documentation for revision requests
For pseudoarthrosis revision without hardware failure, include radiographic demonstration of non-union after 12 months since fusion and document nicotine status; lab nicotine/cotinine ≤10 ng/ml drawn within 6 weeks is required for recent users unless waived.
- Attach CT or dynamic radiographs demonstrating absence of bridging bone or abnormal motion at the fused segment ≥12 months after index fusion.
- Provide lab nicotine/cotinine result if patient used nicotine within the past year.
Imaging report and disagreement documentation required
Advanced imaging official written report (CT, MRI, myelogram) is required prior to any spinal surgery; if the operating surgeon disagrees with the official interpretation, document the disagreement and include a written addendum after discussion with the interpreting provider.
- Include the official imaging report; if surgeon disagrees, provide documented discussion and written addendum to the report.
- Ensure imaging was performed within the past year or after onset of current symptoms as required.
Preoperative physical and neurologic exam documentation required
Medical records must document that a physical examination, including a neurologic exam, was performed by or reviewed by the operating surgeon and be included with authorization requests.
- Include neurologic exam findings (motor, sensory, reflexes) and their correlation with imaging.
- If another clinician performed the exam, include documentation that the operating surgeon reviewed it.
Nicotine cessation documentation required (≤10 ng/ml within 6 weeks)
For fusion, documentation of nicotine-free status is required for recent users: provide lab verification showing blood or urine nicotine or cotinine ≤10 ng/ml drawn within 6 weeks prior to surgery unless an urgent indication applies.
- Attach lab nicotine/cotinine results (80323 or equivalent) dated within 6 weeks of planned surgery.
- If urgent surgery is indicated, document the reason waiver is requested.
Diabetes control documentation required (HbA1c < 8% within 3 months)
For diabetic patients undergoing elective laminectomy or fusion, include HbA1c documentation showing <8% within 3 months prior to surgery unless urgent indication applies.
Coding and supporting imaging must match selection criteria
Ensure coding on authorization requests matches the procedure and diagnosis and include supporting imaging that confirms the implicated level(s) and the clinical selection criteria.
- Use the CPT/HCPCS and ICD-10 codes listed in the policy and attach imaging confirming the diagnosis at the levels to be treated.
- Explain how the codes correspond to the clinical selection criteria.
Relevant diagnostic documentation to include with authorization
Include relevant diagnostic imaging and tests (CT, MRI, MRA, angiography, PET, SPECT) and pertinent labs (HbA1c, nicotine/cotinine) in the authorization to support the requested procedure.
- Attach the formal advanced imaging reports and any additional diagnostic studies referenced in the policy.
- Provide lab evidence for preoperative optimization requirements (A1C, nicotine testing).
Require imaging-confirmed diagnosis and conservative care documentation
Authorization should include imaging-confirmed diagnosis demonstrating implicated level(s) and documentation of prior conservative management attempts as required by the policy selection criteria.
- Specify levels affected on imaging and correlate with clinical findings.
- Provide dates and nature of conservative therapies attempted and their outcomes.
Required clinical documentation for authorization requests
Clinical authorization requests must document the image-confirmed diagnosis, duration of symptoms, neurologic signs, prior conservative treatments and response, and the imaging modality used (MRI preferred) to demonstrate candidacy for surgery.
- Include symptom onset date and duration (e.g., ≥12 weeks where applicable).
- Provide neurologic exam findings and imaging modality details.
Preoperative diagnostic and psychosocial assessment documentation
Perform and document a thorough preoperative diagnostic evaluation including history to exclude extra-spinal causes, identify specific spinal etiology, and assess psychosocial factors—include this assessment in authorization materials.
- Provide notes addressing exclusion of non-spinal pain sources and psychosocial risk factors that may affect outcomes.
- Attach assessments or referrals (e.g., PM&R, psychology) if performed.
Clinical rationale and indication documentation required
Document the clinical rationale and indication for the chosen surgical technique, citing comparative studies or guideline recommendations where relevant to support the request.
- Explain why fusion (and which fusion technique) is indicated rather than decompression alone or structured non-surgical care.
- Reference guideline or comparative evidence when pertinent to the clinical decision.
Exploration of fusion (CPT 22830) — reimbursement limits and denial risk
Exploration of spinal fusion (CPT 22830) is considered incidental to other procedures in the same anatomic region and cannot be authorized in combination with other spinal procedures; billing CPT 22830 separately when incidental may trigger denial.
Experimental/Unproven Procedures may be denied
Procedures listed as experimental, investigational, or unproven (including avulsion of spinal nerves, several laminectomy/fusion indications not listed as medically necessary, ILIF and Coflex-F, and computer-assisted navigation for laminectomies) are not approvable and may be denied.
- Do not submit authorization requests for procedures explicitly listed as experimental unless supported by criteria that make them medically necessary per the CPB.
- If such a procedure is proposed, provide robust evidence and rationale aligned with policy exceptions.
Non-covered ICD-10 examples — nicotine/tobacco use
ICD-10 codes for nicotine dependence (F17.200–F17.299) and tobacco use (Z72.0) are listed as not covered for indications in the CPB and may trigger noncoverage or denial if used as primary indications for spinal procedures.
- Avoid using nicotine dependence or tobacco use codes as the primary indication for spinal surgery requests.
- If present, include the primary spinal diagnosis that meets policy selection criteria.
Non-covered ICD-10 examples (continued) — other not-covered diagnoses
Additional ICD-10 codes (e.g., thrombotic internal jugular vein codes) and other diagnosis codes enumerated in the policy are listed as not covered for CPB indications and may trigger denial if used inappropriately as indications for spinal procedures.
- Ensure the ICD-10 diagnosis submitted corresponds to a covered indication in the CPB and is supported by imaging and clinical documentation.
Potential noncovered indications — policy-listed ICD-10 codes
ICD-10 codes explicitly listed as not covered for CPB indications (including nicotine dependence and tobacco use) may lead to noncoverage; do not rely on these codes as the primary justification for spinal procedures.
- If such codes appear, clarify the primary covered spinal diagnosis and provide supporting imaging and conservative care history.
Not-covered procedure codes may trigger denial
Certain CPT/HCPCS codes (e.g., 61783, S2900, 64772, tissue transfer codes 14000–15734) are listed as not covered for the CPB indications and may trigger denial if billed for those indications; ensure correct procedure coding and justification.
- If billing codes listed as not covered are proposed, provide policy-based justification or avoid separate billing for items considered integral to primary procedures.
Contraindications that may lead to denial of fusion
Absolute and relative contraindications listed in the policy (e.g., initial laminectomy/discectomy for unilateral compression as an absolute contraindication; current smoking, prolonged disability, major psychiatric illness as relative contraindications) may lead to denial of fusion—document contraindication assessment and rationale when requesting fusion.
- Address presence or absence of listed contraindications in the preoperative assessment.
- If relative contraindications exist, document justification for proceeding and any optimization attempts.
Evidence- and indication-based denial risk
If the requested surgery lacks evidence of long-term benefit for the indication (e.g., non-radicular low back pain without failed intensive rehab), authorization may be denied; ensure documentation links indication to policy-supported evidence or exceptions.
- Provide evidence that the patient meets indication-specific criteria and has exhausted applicable conservative or structured therapies.
Evidence insufficiency may affect authorization — provide indication-specific rationale
Insufficient evidence to support certain fusion techniques or superiority of fusion over non-surgical or decompression-alone approaches may affect authorization decisions; include comparative rationale and indication-specific evidence when requesting fusion.
- Cite indication-specific studies or guidelines (e.g., spondylolisthesis vs stenosis) that support the chosen procedure.
- Document why non-operative or decompression-alone options are inadequate for this patient.
Smoking-related non-union risk — document cessation and labs
Smoking is associated with a higher risk of delayed union or non-union after spinal fusion (≈2.2x); failure to document smoking status, cessation counseling or lab verification for recent users could influence coverage and outcomes.
- Document smoking status and cessation efforts; include lab nicotine/cotinine results for recent users per policy requirements.
- Describe counseling or enrollment in cessation programs in pre-op documentation.
Risk from missed AOD diagnosis — document assessment
Missed diagnosis of atlanto‑occipital dissociation (AOD) was associated with higher mortality; authorization and preoperative work-up for occipito-cervical procedures should document assessment for AOD and include CT/MRI criteria when relevant.
- Include CT/MRI evaluation and radiographic criteria (BDI, BAI, condyle–C1 interval) when occipito-cervical instability is suspected.
- Document whether AOD was considered and how it was ruled in/out.
Missed AOD increases mortality — document diagnosis and treatment
Failure to diagnose AOD in trauma cohorts was strongly associated with increased 90‑day mortality; document that AOD was assessed and treated when present to support appropriateness of occipito‑cervical fusion requests.
- Attach radiographic measurements meeting AOD criteria if present (BDI > 10 mm, BAI anterior >12 mm or posterior >4 mm, condyle–C1 interval >1.4 mm).
- If AOD is present, document the rationale for urgent fixation.
Longer operative durations with robotic-assisted fusion — document justification
Robotic-assisted lumbar fusion has been associated with longer operative durations; if robotic technique is used, document justification for its use and provide details supporting the selection to avoid potential coverage questions related to increased operative time.
- Provide rationale for robotic assistance (complex anatomy, deformity) and detail expected benefits (accuracy, reduced revisions) in the request.
- Include planned verification steps and surgeon experience to support safety.
Background, Evidence Summaries, and Rationale
This policy addresses surgical decompression (laminectomy, discectomy, laminoplasty) and spinal fusion for cervical, thoracic, lumbar and sacral indications such as neural compression, fractures, infection, tumor, and deformity. Coverage for listed CPT procedures is conditional on meeting the policy's clinical selection criteria (imaging confirmation and correlated neurologic findings, documented conservative care when required), and many procedures therefore require documentation to support medical necessity.
Clinical decisions about surgery are made in the context of conservative management expectations and trial duration. For radiculopathy and sciatica, conservative care is typically tried for 4–6 weeks before advanced imaging or surgery is considered unless red‑flag indications exist. For lumbar fusion specifically, conservative treatments are commonly tried for 6–12 months prior to considering fusion for axial low back pain, and shared decision‑making should include consideration of intensive rehabilitation alternatives.
The policy background summarizes guideline and technology assessment findings that, for lumbar fusion considered for axial low back pain, conservative treatments are usually attempted for at least 6 to 12 months and that fusion’s benefits for degenerative disc disease are uncertain compared with non‑surgical care, particularly in older patients.
The provided excerpts do not specify a formal step‑therapy program; the document notes that some trials compare structured non‑surgical programs with surgery but no prescriptive step therapy protocol is outlined in this excerpt.
Comparative evidence suggests minimally invasive decompression that preserves posterior elements may be an effective alternative to laminectomy plus fusion for selected patients with degenerative spondylolisthesis; meta‑analytic syntheses indicate MID can reduce operative time, blood loss, and hospital stay while yielding comparable complication rates in selected cohorts.
Preoperative evaluation requirements include documentation of a clinical history and a physical examination with a neurologic exam performed by or reviewed by the operating surgeon. These pre‑op findings, together with imaging, form the basis for determining whether selection criteria for surgical procedures are met.
Clinical studies cited in the policy commonly report standardized outcome measures including Visual Analog Scale (VAS), Neck Disability Index (NDI), and Japanese Orthopaedic Association (JOA) scores, along with radiographic parameters (e.g., Cobb angles, canal occupying ratios, sagittal alignment) to assess clinical and radiographic effects of decompression, fusion, and reconstructive procedures.
From a billing and reimbursement perspective, exploration of spinal fusion (CPT 22830) is treated as incidental to other procedures in the same anatomic region and therefore is subject to limited separate reimbursement; this rule is an important factor in prior authorization and claims adjudication for spinal procedures.
Clinical Definitions and Thresholds
Policy Revision History
Policy became effective on 2007-12-14.
Policy last reviewed on 2026-07-30.
Next scheduled review dated 2026-08-13.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.